ESC 365 - Rationale for new treatment options for intermediate high risk PE patients.

Open Access

Rationale for new treatment options for intermediate high risk PE patients.

Session: Acoustic pulse thrombolysis treatment for pulmonary embolism patients: rationale, experience and data

Topic: Treatment

Speaker: Professor N. Meneveau (Besancon, FR)

Sponsored by EKOS Corporation

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Nicolas Meneveau

Regional University Hospital Jean Minjoz, Besancon (France)

10 presentations

0 follower

2 more presentations in this session

OPTALYSE PE trial long term data: multiple protocols, one treatment.

Speaker: Professor A. Sharp (Dublin, IE)

How do I treat my high risk PE patients with acoustic pulse thrombolysis.

Speaker: Doctor A. Kraaijeveld (Utrecht, NL)

Access the full session

Acoustic pulse thrombolysis treatment for pulmonary embolism patients: rationale, experience and data

Speakers: Professor N. Meneveau, Professor A. Sharp, Doctor A. Kraaijeveld

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources